Iskandar R. Idris

Nottingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 150 publications

Priorities, Expectations, Perceptions of Time in Tight Range and Support Needs Relating to Closed-Loop Therapy Among Adults With Type 1 Diabetes: The SELECT HCL Study.

Priorities, Expectations, Perceptions of Time in Tight Range and Support Needs Relating to Closed-Loop Therapy Among Adults With Type 1 Diabetes: The SELECT HCL Study.

Journal: Diabetes, obesity & metabolism
Published: May 21, 2026

Associations Between Patient-Reported Outcomes and Glycaemic Exposure in Continuous Glucose Monitoring Users With Insulin-Treated Diabetes Receiving Haemodialysis.

Associations Between Patient-Reported Outcomes and Glycaemic Exposure in Continuous Glucose Monitoring Users With Insulin-Treated Diabetes Receiving Haemodialysis.

Journal: Diabetes, obesity & metabolism
Published: April 27, 2026

Continuous Glucose Monitoring in Adults With Diabetes Receiving Haemodialysis: Identifying Dialysis-Specific Glycaemic Patterns and Associations With Volume Status and Intradialytic Hypoglycaemia.

Continuous Glucose Monitoring in Adults With Diabetes Receiving Haemodialysis: Identifying Dialysis-Specific Glycaemic Patterns and Associations With Volume Status and Intradialytic Hypoglycaemia.

Journal: Diabetes, obesity & metabolism
Published: March 02, 2026

The Effect of β-Hydroxy-β-Methyl Butyrate (HMB) upon Acute Fed-State Muscle Protein Turnover in Older Men and Women: A Randomized Double-Blind Controlled Crossover Clinical Trial.

The Effect of β-Hydroxy-β-Methyl Butyrate (HMB) upon Acute Fed-State Muscle Protein Turnover in Older Men and Women: A Randomized Double-Blind Controlled Crossover Clinical Trial.

Journal: Nutrients
Published: February 24, 2026

Emerging Role of Taste Receptors, Entero-Endocrine Cells in Type 2 Diabetes and Metabolic Disorders.

Emerging Role of Taste Receptors, Entero-Endocrine Cells in Type 2 Diabetes and Metabolic Disorders.

Journal: Nutrients
Published: January 11, 2026

The Impact of a Fat-Dominant Preload Before a Carbohydrate-Rich Meal on Glucose Homeostasis in Patients Without Diabetes After Sleeve Gastrectomy: A Proof-of-Concept, Randomised, Open-Label, Crossover Study.

The Impact of a Fat-Dominant Preload Before a Carbohydrate-Rich Meal on Glucose Homeostasis in Patients Without Diabetes After Sleeve Gastrectomy: A Proof-of-Concept, Randomised, Open-Label, Crossover Study.

Journal: Nutrients
Published: January 05, 2026

The Effect of Acute Aerobic Exercise On the Time Spent in Hypoglycaemia After Bariatric Surgery (The BariEX Study).

The Effect of Acute Aerobic Exercise On the Time Spent in Hypoglycaemia After Bariatric Surgery (The BariEX Study).

Journal: Obesity surgery
Published: December 11, 2025

The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation.

The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation.

Journal: Current obesity reports
Published: October 26, 2025

The long-term impact of early HbA1c control on nephropathy, neuropathy, and retinopathy in type 2 diabetes: Findings from a large UK observational study.

The long-term impact of early HbA1c control on nephropathy, neuropathy, and retinopathy in type 2 diabetes: Findings from a large UK observational study.

Journal: Journal of diabetes and its complications
Published: October 13, 2025

The use of the electronic frailty index to optimise HbA1c targets in older individuals with type 2 diabetes.

The use of the electronic frailty index to optimise HbA1c targets in older individuals with type 2 diabetes.

Journal: Age and ageing
Published: September 19, 2025

Diabetes and technology - an update for the general physician.

Diabetes and technology - an update for the general physician.

Journal: Clinical medicine (London, England)
Published: August 08, 2025

Pharmacological weight loss with incretin-based therapies does not result in a disproportionate loss of muscle mass or function in obese mice and humans.

Pharmacological weight loss with incretin-based therapies does not result in a disproportionate loss of muscle mass or function in obese mice and humans.

Journal: medRxiv : the preprint server for health sciences
Published: August 06, 2025
Showing 1-12 of 150

Last Updated: 09/26/2026